( ) saw a significant drop in short interest for the month of march. On March 31, there were 1,500 short shares, which is a 70.6% decrease from the total of 5,100 on March 15. The short-interest rate is currently 0.0 days based on an average daily share volume of 60.400. About 0.0% of a company's stock is short sold.
Golden Arrow Merger Price Performance
The price of the stock remained unchanged at $10.14 on Friday. The average trading volume for the company is 4,300 shares. However, only 38 shares were traded. The company's 50-day moving average is $10.14, and its 200-day moving average is $10.04. Recently, a number of institutional investors bought and sold the company's shares. UBS Group AG increased its holdings of Golden Arrow Merger during the second quarter by 9,270.4%. After acquiring 3,200 additional shares, the company now holds 18,857 of its stock valued at $185,000 and has now acquired 18,857. First Trust Capital Management L.P. increased its holdings of Golden Arrow Merger during the fourth quarter by 2.2%. First Trust Capital Management L.P. owns 270.884 shares worth $2.713,000, after adding 5,785 more shares. Dark Forest Capital Management LP increased its holdings of Golden Arrow Merger during the fourth quarter by 219.3%. Dark Forest Capital Management LP owns 10,273 of the company stock, worth $103,000. This is after acquiring 7,056 additional shares. Virtu Financial LLC increased its holdings of Golden Arrow Merger during the fourth quarter by 17.8%. Virtu Financial LLC owns 48.108 shares worth $482,000. This is after adding 7,283 additional shares. 67.36% is owned by institutional investors and hedge fund.
Golden Arrow Merger
Golden Arrow Merger Corp. has no significant operations. The company intends on a merger, reorganization or other similar business combination, with one or more companies in the healthcare industry or infrastructure related to healthcare in the United States or other developed countries.
MarketBeat.com offers a FREE daily email newsletter